The sales of Renin-Angiotensin System medicines in Germany are forecasted to rise from $2.8 billion in 2024 to $3.04 billion in 2028. This marks a consistent year-on-year growth reflecting an annual increase of approximately 2.14% compounded annually over five years. The forecast indicates a steady upward trend in this pharmaceutical segment since 2023.

Future trends to watch for:

Technological advancements and innovation in drug formulations that may drive further market growth.
Potential regulatory changes affecting market dynamics and pricing.
Shifts in population demographics and prevalence rates of hypertension and cardiac ailments.